Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of Thrombosis and Thrombolysis
|
January 12, 2011
Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel
Fabio Mangiacapra, Aaron J Peace, William Wijns, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
February 21, 2012
High cholesterol levels are associated with coronary microvascular dysfunction
Fabio Mangiacapra, Bernard De Bruyne, Aaron J Peace, et al.
Rheumatology (Oxford, England)
|
December 8, 2009
Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target
Paul A Mac Mullan, Aaron J Peace, Anne M Madigan, et al.
Journal of Electrocardiology
|
September 15, 2017
A decision support system and rule-based algorithm to augment the human interpretation of the 12-lead electrocardiogram
Andrew W Cairns, Raymond R Bond, Dewar D Finlay, et al.
Clinical Rheumatology
|
September 26, 2014
Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis
Paul A MacMullan, Anne M Madigan, Nevin Paul, et al.
Journal of Biomedical Informatics
|
October 1, 2016
A computer-human interaction model to improve the diagnostic accuracy and clinical decision-making during 12-lead electrocardiogram interpretation
Andrew W Cairns, Raymond R Bond, Dewar D Finlay, et al.
JACC. Cardiovascular Interventions
|
March 24, 2012
A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study
Fabio Mangiacapra, Giuseppe Patti, Emanuele Barbato, et al.
Journal of the American College of Cardiology
|
January 8, 2013
Intracoronary EnalaPrilat to Reduce MICROvascular Damage During Percutaneous Coronary Intervention (ProMicro) study
Fabio Mangiacapra, Aaron J Peace, Luigi Di Serafino, et al.
BMC Pulmonary Medicine
|
August 9, 2020
Spontaneous regression of ALK fusion protein-positive non-small cell lung carcinoma: a case report and review of the literature
Maria Walls, Gerard M Walls, Jacqueline A James, et al.
Atherosclerosis
|
September 22, 2018
Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel
Fabio Mangiacapra, Mariano Pellicano, Luigi Di Serafino, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of Thrombosis and Thrombolysis
|
January 12, 2011
Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel
Fabio Mangiacapra, Aaron J Peace, William Wijns, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
February 21, 2012
High cholesterol levels are associated with coronary microvascular dysfunction
Fabio Mangiacapra, Bernard De Bruyne, Aaron J Peace, et al.
Rheumatology (Oxford, England)
|
December 8, 2009
Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target
Paul A Mac Mullan, Aaron J Peace, Anne M Madigan, et al.
Journal of Electrocardiology
|
September 15, 2017
A decision support system and rule-based algorithm to augment the human interpretation of the 12-lead electrocardiogram
Andrew W Cairns, Raymond R Bond, Dewar D Finlay, et al.
Clinical Rheumatology
|
September 26, 2014
Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis
Paul A MacMullan, Anne M Madigan, Nevin Paul, et al.
Journal of Biomedical Informatics
|
October 1, 2016
A computer-human interaction model to improve the diagnostic accuracy and clinical decision-making during 12-lead electrocardiogram interpretation
Andrew W Cairns, Raymond R Bond, Dewar D Finlay, et al.
JACC. Cardiovascular Interventions
|
March 24, 2012
A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study
Fabio Mangiacapra, Giuseppe Patti, Emanuele Barbato, et al.
Journal of the American College of Cardiology
|
January 8, 2013
Intracoronary EnalaPrilat to Reduce MICROvascular Damage During Percutaneous Coronary Intervention (ProMicro) study
Fabio Mangiacapra, Aaron J Peace, Luigi Di Serafino, et al.
BMC Pulmonary Medicine
|
August 9, 2020
Spontaneous regression of ALK fusion protein-positive non-small cell lung carcinoma: a case report and review of the literature
Maria Walls, Gerard M Walls, Jacqueline A James, et al.
Atherosclerosis
|
September 22, 2018
Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel
Fabio Mangiacapra, Mariano Pellicano, Luigi Di Serafino, et al.
Page
of 2